Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Silvia Bellando-Randone, Susanna Cappelli, Serena Guiducci, Laura Cometi & Marco Matucci-Cerinic. (2013) Treatment options in systemic sclerosis. Expert Opinion on Orphan Drugs 1:11, pages 851-865.
Read now
Read now
Mohammad Amin Rezvanfar, Hamid Reza Rahimi & Mohammad Abdollahi. (2012) ADMET considerations for phosphodiesterase-5 inhibitors. Expert Opinion on Drug Metabolism & Toxicology 8:10, pages 1231-1245.
Read now
Read now
Debendra Pattanaik, Monica Brown & Arnold E Postlethwaite. (2011) Vascular involvement in systemic sclerosis (scleroderma). Journal of Inflammation Research 4, pages 105-125.
Read now
Read now
A Della Rossa, M Doveri, A D'Ascanio, A Tavoni, A Consensi, R Neri, L Bazzichi & S Bombardieri. (2011) Oral sildenafil in skin ulcers secondary to systemic sclerosis. Scandinavian Journal of Rheumatology 40:4, pages 323-325.
Read now
Read now
Articles from other publishers (20)
Colletti, Galardi, Santis, Guidelli, Giannatale, Luigi & Antinozzi. (2019) Exosomes in Systemic Sclerosis: Messengers Between Immune, Vascular and Fibrotic Components?. International Journal of Molecular Sciences 20:18, pages 4337.
Crossref
Crossref
Niloufar Kavian & Frédéric Batteux. (2015) Macro- and microvascular disease in systemic sclerosis. Vascular Pharmacology 71, pages 16-23.
Crossref
Crossref
Swenn Maxence Krähenbühl, Michele Depairon, Marguerite Faure, Naik Vietti Violi, Lee Ann Applegate & Wassim Raffoul. (2015) Sildenafil as a Therapeutic Option for Digital Ischemic Ulceration: Case Report. The Journal of Hand Surgery 40:5, pages 890-893.
Crossref
Crossref
E. Y. Lee, J. K. Park, W. Lee, Y. K. Kim, C. S.-Y. Park, J. T. Giles, J. W. Park, K. Shin, J. S. Lee, Y. W. Song & E. B. Lee. (2013) Head-to-head comparison of udenafil vs amlodipine in the treatment of secondary Raynaud's phenomenon: a double-blind, randomized, cross-over study. Rheumatology 53:4, pages 658-664.
Crossref
Crossref
Dominique Hervé, Anne Philippi, Reda Belbouab, Michel Zerah, Stéphane Chabrier, Sophie Collardeau-Frachon, Francoise Bergametti, Aurore Essongue, Eliane Berrou, Valérie Krivosic, Christian Sainte-Rose, Emmanuel Houdart, Frédéric Adam, Kareen Billiemaz, Marilyne Lebret, Sabine Roman, Sandrine Passemard, Gwenola Boulday, Audrey Delaforge, Stéphanie Guey, Xavier Dray, Hugues Chabriat, Peter Brouckaert, Maryjke Bryckaert & Elisabeth Tournier-Lasserve. (2014) Loss of α1β1 Soluble Guanylate Cyclase, the Major Nitric Oxide Receptor, Leads to Moyamoya and Achalasia. The American Journal of Human Genetics 94:3, pages 385-394.
Crossref
Crossref
Matthieu Roustit, Sophie Blaise, Yannick Allanore, Patrick H Carpentier, Evren Caglayan & Jean-Luc Cracowski. (2013) Phosphodiesterase-5 inhibitors for the treatment of secondary Raynaud's phenomenon: systematic review and meta-analysis of randomised trials. Annals of the Rheumatic Diseases 72:10, pages 1696-1699.
Crossref
Crossref
Steven G. Chrysant. (2013) Effectiveness and Safety of Phosphodiesterase 5 Inhibitors in Patients with Cardiovascular Disease and Hypertension. Current Hypertension Reports 15:5, pages 475-483.
Crossref
Crossref
Percival Degrava Sampaio-Barros, Adriana Fontes Zimmermann, Carolina de Souza Müller, Cláudia Tereza Lobato Borges, Eutília Andrade Medeiros Freire, Giselle Baptista Maretti, João Francisco Marques Neto, Maria Cecília Fonseca Salgado, Maria de Fátima Lobato da Cunha Sauma, Mário Newton Leitão de Azevedo, Sheila Fontenelle & Cristiane Kayser. (2013) Recomendações sobre diagnóstico e tratamento da esclerose sistêmica. Revista Brasileira de Reumatologia 53:3, pages 258-275.
Crossref
Crossref
P. Sinnathurai & L. Schrieber. (2013) Treatment of Raynaud phenomenon in systemic sclerosis. Internal Medicine Journal 43:5, pages 476-483.
Crossref
Crossref
Percival Degrava Sampaio-Barros, Adriana Fontes Zimmermann, Carolina de Souza Müller, Cláudia Tereza Lobato Borges, Eutília Andrade Medeiros Freire, Giselle Baptista Maretti, João Francisco Marques Neto, Maria Cecília Fonseca Salgado, Maria de Fátima Lobato da Cunha Sauma, Mário Newton Leitão de Azevedo, Sheila Fontenelle & Cristiane Kayser. (2013) Recommendations for the management and treatment of systemic sclerosis. Revista Brasileira de Reumatologia (English Edition) 53:3, pages 258-275.
Crossref
Crossref
Sophie E. McGrath, Andrew Webb & Karen Walker-Bone. (2013) Bleomycin-Induced Raynaud's Phenomenon After Single-Dose Exposure: Risk Factors and Treatment With Intravenous Iloprost Infusion. Journal of Clinical Oncology 31:4, pages e51-e52.
Crossref
Crossref
Alejandro Nitsche. (2012) Raynaud, Digital Ulcers and Calcinosis in Scleroderma. Reumatolog?a Cl?nica (English Edition) 8:5, pages 270-277.
Crossref
Crossref
Alejandro Nitsche. (2012) Raynaud, ?lceras digitales y calcinosis en esclerodermia. Reumatolog?a Cl?nica 8:5, pages 270-277.
Crossref
Crossref
M Roustit, M Hellmann, C Cracowski, S Blaise & J L Cracowski. (2012) Sildenafil Increases Digital Skin Blood Flow During All Phases of Local Cooling in Primary Raynaud's Phenomenon. Clinical Pharmacology & Therapeutics 91:5, pages 813-819.
Crossref
Crossref
Delphine Vezzosi & Jérôme Bertherat. (2011) Phosphodiesterases in endocrine physiology and disease. European Journal of Endocrinology 165:2, pages 177-188.
Crossref
Crossref
E. J. Trip & W. H. Hirdes. (2011) De winterpenis. Tijdschrift voor Urologie 1:4, pages 98-100.
Crossref
Crossref
Sharron H. Francis, Mitsi A. Blount & Jackie D. Corbin. (2011) Mammalian Cyclic Nucleotide Phosphodiesterases: Molecular Mechanisms and Physiological Functions. Physiological Reviews 91:2, pages 651-690.
Crossref
Crossref
Anne Mawdsley. (2011) Raynaud’s phenomenon: what can be done for patients?. British Journal of Healthcare Assistants 5:3, pages 130-133.
Crossref
Crossref
Ariane L. Herrick, Frank van den Hoogen, Armando Gabrielli, Nihad Tamimi, Carol Reid, Damian O'Connell, Maria-Dolores V?zquez-Abad & Christopher P. Denton. (2011) Modified-release sildenafil reduces Raynaud's phenomenon attack frequency in limited cutaneous systemic sclerosis. Arthritis & Rheumatism 63:3, pages 775-782.
Crossref
Crossref
Alan W. Shindel. (2009) Continuing Medical Education: 2009 Update on Phosphodiesterase Type 5 Inhibitor Therapy Part 1: Recent Studies on Routine Dosing for Penile Rehabilitation, Lower Urinary Tract Symptoms, and Other Indications (CME). The Journal of Sexual Medicine 6:7, pages 1794-1808.
Crossref
Crossref